Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | — | RA |
Large, red, swollen location, warm to touch, 3-4 inches across, at the injection site; Large, red, swollen location, warm to touch, 3-4 inches across, at the injection site; Large, red, swollen location, warm to touch, 3-4 inches across, at the injection site; This is a spontaneous report received from a Consumer or other non HCP. A 52-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 14May2025 at 09:00 as dose 1, single (Batch/Lot number: unknown) at the age of 52 years, in right arm for immunisation. The patient's relevant medical history included: "Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE WARMTH (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 14May2025 at 10:00, outcome "recovering" and all described as "Large, red, swollen location, warm to touch, 3-4 inches across, at the injection site". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site warmth, vaccination site swelling. Additional information: As of 14May2025, facility where vaccine was administered was doctor's office/urgent care. The patient did not receive any other vaccines on the same date as the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. It was unknown whether the patient was taking any other medications within 2 weeks of the event starting. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Allergy